In the Women’s IP World Annual 2026, Michele S. Katz and Noa Siskind of Advítam IP examine how the rise of GLP-1 drugs such as Ozempic® is testing the limits of trademark law, false advertising, and consumer protection in the digital age.

In the Women’s IP World Annual 2025, Michele Katz reflects on the evolution of the Women’s IP World Podcast, highlighting its mission to amplify diverse voices and inspire women across the global IP community.